Author

K.-K. Au

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 6 Approach:experimental assay· 5 Organism:human· 4 Assay:proteomics· 3 Assay:flow cytometry· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

K.-Y. Yuen· 6 shared R. Zhou· 6 shared Z. Chen· 6 shared H. Huang· 5 shared N. Liu· 5 shared Q. Peng· 5 shared D. Yang· 4 shared K. K.-W. To· 4 shared

Activity by Year

2021-2022 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

6 shared papersImmunology

K.-Y. Yuen

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron-BA.2

R. Zhou, N. Liu, X. Li, Q. Peng, C.-K. Yiu, H. Huang, D. Yang, Z. Du, H.-Y. Kwok, K.-K. Au, J.-P. Cai, I. F.-N. Hung, K. K.-W. To, X. Xu, K.-Y. Yuen, Z. Chen

This study evaluates the effectiveness of three-dose SARS-CoV-2 vaccination against Omicron BA.2 breakthrough infections and finds that third-dose vaccination significantly reduces infection rates and severity.

bioRxiv · May 9, 2022 · PreprintImmunology

An elite broadly neutralizing antibody protects SARS-CoV-2 Omicron variant challenge

B. Zhou, R. Zhou, J. F.-W. Chan, M. Luo, Q. Peng, S. Yuan, B. W.-Y. Mok, B. Chen, P. Wang, V. K.-M. Poon, H. Chu, C. C.-S. Chan, J. O.-L. Tsang, C. C.-Y. Chan, K.-K. Au, , Z. Chen

This study identifies a broadly neutralizing antibody, ZCB11, effective against SARS-CoV-2 Omicron and Delta variants, showing protection in hamsters.

bioRxiv · Jan 5, 2022 · PreprintImmunology

Vaccine-breakthrough infection by the SARS-CoV-2 Omicron variant elicits broadly cross-reactive immune responses

R. Zhou, K. K.-W. To, Q. Peng, J. M.-C. Chan, H. Huang, D. Yang, B. H.-S. Lam, V. W.-M. Chuang, J.-P. Cai, N. Liu, K.-K. Au, O. T.-Y. Tsang, K.-Y. Yuen, Z. Chen

This study examines immune responses in vaccine-breakthrough Omicron infections, finding rapid cross-reactive neutralizing antibodies and T cell responses against multiple variants.

bioRxiv · Dec 27, 2021Immunology

Waning immune responses against SARS-CoV-2 among vaccinees in Hong Kong

Q. Peng, R. Zhou, Y. Wang, M. Zhao, N. Liu, S. Li, H. Huang, D. Yang, K.-K. Au, H. Wang, K. Man, K.-Y. Yuen, Z. Chen

This study compares immune responses between BioNTech and Sinovac vaccines in Hong Kong, finding Sinovac induces lower neutralizing antibodies and wanes faster against SARS-CoV-2 variants.

bioRxiv · Dec 22, 2021 · PreprintImmunology

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination

R. Zhou, P. Wang, Y.-C. Wong, H. Xu, S.-Y. Lau, L. Liu, B. W.-Y. Mok, Q. Peng, N. Liu, S. Deng, R. C.-Y. Tam, H. Huang, A. J. Zhang, D. Zhou, B. Zhou, , Z. Chen

This study shows that intranasal influenza-based boost vaccination enhances mucosal and systemic immunity against SARS-CoV-2, effectively preventing infection in both upper and lower respiratory systems.

bioRxiv · Oct 21, 2021 · PreprintImmunology

SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury

B. Zhou, R. Zhou, J. F.-W. Chan, J. Zeng, Q. Zhang, S. Yuan, L. Liu, R. Robinot, S. Shan, J. Ge, H. Y.-H. Kwong, D. Zhou, H. Xu, C. C.-S. Chan, V. K.-M. Poon, , Z. Chen

This study shows that dimeric IgA antibodies can enhance SARS-CoV-2 nasal infection and injury in Syrian hamsters by engaging CD209 as an alternative receptor.

bioRxiv · Oct 5, 2021 · PreprintMicrobiology